
A GRAND FEAST
Zomato’s gross order value in the September quarter of FY25 for its B2C business stood at ₹17,670 crore, showing a 55% year-on-year growth
The adjusted revenue of the company has shown 58% year-on-year growth, standing at ₹5,127 crore. In the previous quarter, the adjusted revenue was ₹4,520 crore
Adjusted Ebitda in Q2 was ₹330 crore and continues to show improvement with an increase in food delivery margins. The quick commerce business reached break-even. It had turned Ebitda positive in March 2024
IN JULY 2022, just a year after debuting in the stock exchange at ₹115, Zomato’s share price nosedived to below ₹50. Its future seemed uncertain. A nonprofitable start-up hitting the stock market was a bold move—and, to some, even reckless. Investors braced for losses, shaking their heads at what felt like the bubble ready to burst.
Fast forward to 2024, and the tables have turned. In December 2024, Zomato’s stock price soared to an all-time high of ₹304.5 per share. It is because of its remarkable turnaround that secured its entry into the Top 50 in the BT500 list of India’s Most Valuable Companies.
Who could have foreseen that what began as Foodiebay, a modest online restaurant directory, would evolve into one of India’s most coveted start-ups, shaping the nation’s business landscape under Founder, Managing Director and Chief Executive Officer Deepinder Goyal?
THE GROWTH STORY
هذه القصة مأخوذة من طبعة December 22, 2024 من Business Today India.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة December 22, 2024 من Business Today India.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول

REACHING FOR THE COUNTERS
DESPITE HEALTH CONCERNS, THE INCREASING POPULARITY OF OTC DRUGS HAS LED TO PHARMA MAJORS SEIZING THE CHANCE TO DIVERSIFY THEIR REVENUE STREAMS. THE RISING POPULARITY OF SKINCARE AND PERSONAL HEALTH HAS LED TO EASY ACCESS OF SEVERAL DERMATOLOGICAL PRODUCTS. FROM D2C BRANDS TO ESTABLISHED PLAYERS, PHARMA COMPANIES ARE LOOKING TO BITE INTO THE PIE

the art of time
THE SIXTH EDITION OF THE LVMH WATCH WEEK WAS HELD IN NEW YORK AND PARIS RECENTLY. WE LOOK AT SOME OF THE LATEST CREATIONS SHOWCASED

Celestial Disruption
ASTROLOGY, OR THE STUDY OF THE FUTURE FORETOLD BY CELESTIAL BODIES, IS EXPERIENCING A COSMIC TRANSFORMATION, FUELLED BY DIGITAL DISRUPTION, ARTIFICIAL INTELLIGENCE, AND A $7-BILLION FAITH MARKET

"MANUFACTURING HAS MOVED TO THE FOREFRONT"
Rahul Jain, BCG India Head, on the future of manufacturing, how India can capitalise on global trends and more

"Reignite the spirit of ownership"
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company

TRICITY TRIUMPHS
CHANDIGARH, MOHALI & PANCHKULA DELIVERED SOME OF THE LONGEST DRIVES THIS SEASON

"AIM TO TRIPLE PROFITS TO ₹2,500 CRORE BY FY28”
Anand Roy, MD and CEO of Star Health Insurance, on the future of the company, challenges in the health insurance sector, and more

WHITHER THE RUPEE?
THE RUPEE HAS DECLINED SHARPLY ALONG WITH OTHER CURRENCIES AS THE DOLLAR HAS STRENGTHENED AFTER DONALD TRUMP TOOK OFFICE AS THE PRESIDENT OF THE US. WILL THE RUPEE CONTINUE TO DEPRECIATE AND WHAT WILL THE IMPACT BE ON INDIA'S ECONOMY?

"Some of our states have to introspect and get their act together"
Finance Minister Nirmala Sitharaman on the measures announced in the recent Budget, India's growth prospects, global uncertainty and more

ZOMATO REBRANDED: More Than Just Delivery
With Blinkit growing rapidly, renaming Zomato to Eternal drives home the multifaceted nature of business